论文部分内容阅读
目的探讨盐酸氨溴索注射液治疗小儿支气管肺炎的临床疗效。方法选取2012年10月—2014年3月大同市第一人民医院收治的小儿支气管肺炎患儿70例,随机分为观察组与对照组,各35例。对照组患儿予以常规治疗,观察组在对照组基础上加用盐酸氨溴索注射液治疗。观察两组患儿临床疗效、症状缓解时间、住院时间及不良反应发生情况。结果观察组患儿总有效率高于对照组,气促、咳嗽、肺部啰音、发热缓解时间及住院时间短于对照组,差异有统计学意义(P<0.05);两组患儿均未发生严重不良反应。结论盐酸氨溴索注射液治疗小儿支气管肺炎的临床疗效显著,可缩短患儿症状改善时间及住院时间,且不良反应少。
Objective To investigate the clinical efficacy of ambroxol hydrochloride injection in the treatment of bronchial pneumonia in children. Methods Seventy patients with bronchopneumonia in children admitted to the First People’s Hospital of Datong City from October 2012 to March 2014 were randomly divided into observation group and control group with 35 cases in each group. Children in the control group were treated routinely, and the observation group was treated with ambroxol hydrochloride injection on the basis of the control group. The clinical efficacy, symptom relief time, hospital stay and adverse reactions in both groups were observed. Results The total effective rate of the observation group was higher than that of the control group. There was a significant difference between the two groups (P <0.05). Shortness of breath, cough, pulmonary rales, fever relief time and hospital stay were shorter than those in the control group No serious adverse reactions occurred. Conclusion Ambroxol hydrochloride injection in children with bronchial pneumonia clinical efficacy was significant, can shorten the symptoms of children with improved time and hospital stay, and less adverse reactions.